2022 - Research.com Immunology in Belgium Leader Award
His main research concerns Immunology, Antigen, Cytotoxic T cell, T lymphocyte and CD8. His work deals with themes such as Molecular biology and In vitro, which intersect with Immunology. His Antigen research incorporates elements of Antibody, Melanoma, Immune system and Transplantation.
His study looks at the relationship between Cytotoxic T cell and fields such as Cytotoxicity, as well as how they intersect with chemical problems. His studies in CD8 integrate themes in fields like Epitope, T cell, Ex vivo and Effector. His biological study spans a wide range of topics, including Cell biology, Tumor antigen, Immunotherapy and Cytolysis.
Immunology, Antigen, Molecular biology, Cytotoxic T cell and CTL* are his primary areas of study. His Immunology and T lymphocyte, Immune system, T cell, Spleen and Tumor antigen investigations all form part of his Immunology research activities. His Antigen research includes themes of Antibody, Melanoma and Immunotherapy.
The concepts of his Molecular biology study are interwoven with issues in Cell culture, Lymphokine, MHC class I, Interleukin 2 and Monoclonal antibody. His Cytotoxic T cell study incorporates themes from CD8 and T-cell receptor. His work carried out in the field of CTL* brings together such families of science as Peptide, Cellular immunity, Cytolysis and Virology.
His primary areas of study are Immunology, Cytotoxic T cell, CD8, Antigen and T cell. His studies deal with areas such as Ex vivo and Melanoma as well as Immunology. His Cytotoxic T cell research focuses on subjects like T-cell receptor, which are linked to Avidity and NY-ESO-1.
His study on CD8 is covered under Immune system. His Antigen research is multidisciplinary, incorporating elements of Cancer and Peptide library. He has researched T cell in several fields, including Molecular biology, Dendritic cell and Effector.
His scientific interests lie mostly in CD8, Immunology, Cytotoxic T cell, Antigen and Immune system. As part of the same scientific family, he usually focuses on CD8, concentrating on T cell and intersecting with Dendritic cell. Jean-Charles Cerottini combines topics linked to Melanoma with his work on Immunology.
He has included themes like Molecular biology and T lymphocyte in his Cytotoxic T cell study. His research ties Biophysics and Antigen together. His study in Immune system is interdisciplinary in nature, drawing from both Cancer, Tumor progression and Peptide vaccine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cell-Mediated Cytotoxicity, Allograft Rejection, and Tumor Immunity
Jean-Charles Cerottini;K. Theodore Brunner.
Advances in Immunology (1974)
Tumor-antigens recognized by T-lymphocytes
Thierry Boon;Jean-Charles Cerottini;Benoît Van den Eynde;Pierre van der Bruggen.
Annual Review of Immunology (1994)
Rapid and strong human CD8 + T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909
Daniel E. Speiser;Danielle Liénard;Nathalie Rufer;Verena Rubio-Godoy.
Journal of Clinical Investigation (2005)
GENERATION OF CYTOTOXIC T LYMPHOCYTES IN VITRO : I. RESPONSE OF NORMAL AND IMMUNE MOUSE SPLEEN CELLS IN MIXED LEUKOCYTE CULTURES
Jean-Charles Cerottini;Howard D. Engers;H. Robson MacDonald;K. Theodor Brunner.
Journal of Experimental Medicine (1974)
Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation.
R C Budd;J C Cerottini;C Horvath;C Bron.
Journal of Immunology (1987)
Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes
Pedro Romero;P. Rod Dunbar;Danila Valmori;Mikaël Pittet.
Journal of Experimental Medicine (1998)
High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals
M J Pittet;D Valmori;P R Dunbar;D E Speiser.
Journal of Experimental Medicine (1999)
Decreased specific CD8+ T cell cross‐reactivity of antigen recognition following vaccination with Melan‐A peptide
Victor Appay;Victor Appay;Daniel E. Speiser;Nathalie Rufer;Severine Reynard.
European Journal of Immunology (2006)
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.
Sandra Morel;Frédéric Lévy;Odile Burlet-Schiltz;Francis Brasseur.
Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance
Alfred Zippelius;Pascal Batard;Verena Rubio-Godoy;Gilles Bioley.
Cancer Research (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: